8-132077776-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145095.3(HHLA1):c.1121C>T(p.Ala374Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000129 in 1,551,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001145095.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HHLA1 | NM_001145095.3 | c.1121C>T | p.Ala374Val | missense_variant | 12/17 | ENST00000414222.2 | NP_001138567.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HHLA1 | ENST00000414222.2 | c.1121C>T | p.Ala374Val | missense_variant | 12/17 | 5 | NM_001145095.3 | ENSP00000388322.1 | ||
ENSG00000258417 | ENST00000262283.5 | c.347C>T | p.Ala116Val | missense_variant | 2/18 | 5 | ENSP00000262283.5 | |||
HHLA1 | ENST00000473291.1 | n.1583C>T | non_coding_transcript_exon_variant | 2/7 | 1 | |||||
HHLA1 | ENST00000673615.1 | c.1229C>T | p.Ala410Val | missense_variant | 13/18 | ENSP00000500443.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 31
GnomAD4 exome AF: 7.15e-7 AC: 1AN: 1399382Hom.: 0 Cov.: 34 AF XY: 0.00000145 AC XY: 1AN XY: 690198
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2024 | The c.1121C>T (p.A374V) alteration is located in exon 11 (coding exon 11) of the HHLA1 gene. This alteration results from a C to T substitution at nucleotide position 1121, causing the alanine (A) at amino acid position 374 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at